Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation

Anti-inflammatory properties of histone deacetylase inhibitors

(2016) Wei Chong et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Effects of Antiepileptic Drugs on Antioxidant and Oxidant Molecular Pathways: Focus on Trace Elements

(2013) Mustafa Nazıroğlu et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis

(2013) Katrien Van Beneden et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents

(2012) T. Ahmad et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Pathogenesis of Liver Fibrosis

(2011) Virginia Hernandez-Gea et al.   Annual Review of Pathology-Mechanisms of Disease

The effect of valproic acid in alleviating early death in burn shock

(2011) Sen Hu et al.   BURNS

Valproic Acid Attenuates Proteinuria and Kidney Injury

(2011) K. Van Beneden et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice

(2011) Sabbir Khan et al.   REPRODUCTIVE TOXICOLOGY

Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders

(2010) M. Pang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications

(2010) A. Verrotti et al.   Obesity Reviews

A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

(2009) A Rocca et al.   BRITISH JOURNAL OF CANCER

Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cellsin vitroandin vivo

(2009) Inge Mannaerts et al.   HEPATOLOGY

Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors

(2009) Claudiu Komorowsky et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy

(2008) Sophie Linthout et al.   BASIC RESEARCH IN CARDIOLOGY

Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy

(2008) Jennifer S. Carew et al.   CANCER LETTERS

Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors

(2008) Alfonso Duenas-Gonzalez et al.   CANCER TREATMENT REVIEWS

Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors

(2008) Simone Fulda   CURRENT CANCER DRUG TARGETS

Epigenetic regulation of hepatic stellate cell activation

(2008) Derek A Mann et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Epigenetics and Complex Disease: From Etiology to New Therapeutics

(2007) Carolyn Ptak et al.   Annual Review of Pharmacology and Toxicology